Agenda & Learning Objectives

Participants in this program will:
  • Examine COVID-19 and the impact on IBD practice
  • Examine Theoretical Immune Pathways
    • Consider the future of IBD therapy
    • Discuss emerging pathways
  • Explore new agents
    • Consider where new agents may fit
    • Discuss what is in the pipeline
  • Integrate basic science and clinical practice by participation in a choice of workshop to:
    • Examine the effects of social media and apps on IBD research and practice, or
    • Discuss how to evaluate and integrate information from the internet, or
    • Consider the influence of co-morbidity on IBD, or
    • Reflect on the impact of diet and IBD

NOTE: Junior Investigator Award – Please go to the Call for Abstracts page on the registration site

Time Title/Topic Speakers
10:00 EST Meeting site open for sign in
Lobby open
Sponsor Exhibits open
Photo Booth open
11:00 EST 0.1 Welcome: Nurse &  Physician of the Year Awards, Women in IBD Awards​ (10 mins) Crohn's and Colitis Canada
11:10 EST 0.2 Opening Remarks – Welcome, program objectives (10 mins)
Remo Panaccione & Hillary Steinhart

Session I: COVID-19 and IBD

11:20 EST Plenary Presentation (25 mins)
1.1 What have we learned? Will it change your practice?
Session Objectivives:
  • Overview of Impact Report
  • Examine the effect on practice
  • Discuss the impact of COVID-19 on mental health
  • Explore the immune response to the COVID-19 vaccine
Gilaad Kaplan
11:45 EST Ask-the Expert Panel Session (20 mins) SESSION CHAIR
Eric Benchimol
Gilaad Kaplan
Laura Targownik
1.2 Meeting of the Minds Junior Investigator Award Presentation (20 mins)
Remo Panaccione
Junior Investigator TBA
Refreshment and Network Break (10 mins)  

Session II: New Agents - New Possibilities

12:35 EST Plenary Presentation (15 mins)
2.1 Theoretical Immune Pathways: What is the Evidence?
Session Objectives:
  • Explore the immune pathways and future IBD therapy
  • Emerging pathways targeted by novel agents – ie., IL 17, 22, 23, JAK inhibition, novel lymphocyte migration
Simon Hirota
12:50 EST Plenary Presentation (15 mins)
2.2 New Agents
Session Objectives:
  • New agents targeting new pathways on the horizon
  • Discuss where these agents may fit, alone or in combination
  • Discuss what is in the pipeline
Remo Panaccione
13:05 EST Ask-the Expert Panel Session (20 mins) SESSION CHAIR
Brian Feagan
Reena Khanna
Remo Panaccione
13:25 EST
2.3 Rising Star Award Plenary Presentation (20 mins)​
Kate Lee
Rising Star TBA
13:45 EST Virtual Sponsor Booth and Network Break (30 mins)  

Session III: Workshops – Hot Topics from Bench to Clinic to Policy (45 mins)

  • The number of breakout rooms per topic will be determined by enrolment
  • Delegate attends choice of one 45-minute workshop
  • Facilitators to collaborate on creation of workshop presentation:
    • Each facilitator will moderate one session of 30-minutes either separately in tandem with co-developer depending on final enrolment numbers for workshop (Maximum 30 per room)
14:15 EST Placement into Workshops (5 mins)  
14:20 EST Workshop
3.1 Social Media and Apps in IBD
  • Session Objectives: TBC
Waqqas Afif
Eric Benchimol

3.2 Learning from the Internet: How to Evaluate Information
  • Session Objectives: TBC
Sanjay Murthy
Laura Targownik
3.3 Co-Morbidity Influence on the Course of IBD
  • Session Objectives: TBC
Charles Bernstein
Sharyle Fowler
3.4 Diet and IBD
  • Session Objectives: TBC
Neeraj Narula
Matreyi Raman
15:05 EST Refreshment and Network Break (10 mins)  
15:15 EST
4.1 Research Leadership Award & Presentation
Research Leadership TBA

Session IV: Technology and IBD                             SESSION CHAIR: TBC

4.2 How Technology is Changing IBD Research and Practice
15:35 EST Plenary Presentation (15 mins)
4.2.1 Objectives:
  • Aritificial Intelligence and IBD
Michael Byrne
15:50 EST Plenary Presentation (15 mins)
4.2.2 Objectives:
  • Review new sources of data - GEM
  • Discuss new methods of data collection
  • Explore how new sources of data can be implemented into practice
Sun-Ho Lee
16:05 EST Q&A (10 mins)  
16:15 EST Closing Remarks and Program Evaluation (10 mins) CO-CHAIRS: 
Remo Panaccione & Hillary Steinhart

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.